Literature DB >> 12054665

Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains.

Monique Malléa1, Jacqueline Chevalier, Annie Eyraud, Jean-Marie Pagès.   

Abstract

Enterobacter aerogenes, a nosocomial pathogen, is frequently exhibiting multidrug resistance mechanisms associated with a change in membrane permeability. In clinical isolates, active efflux plays a prominent role in antibiotic resistance. We report here the effect of three unrelated compounds that are able to restore a noticeable antibiotic susceptibility to resistant strains. The targeting of various parameters which contribute to the efficacy of the efflux mechanism, such as energy, flux selectivity, or functional assembly of the membrane complex, increases the intracellular chloramphenicol concentration in resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054665     DOI: 10.1016/S0006-291X(02)00404-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains.

Authors:  Stéphane Gayet; Renaud Chollet; Gérard Molle; Jean-Marie Pagès; Jacqueline Chevalier
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.

Authors:  Yi-Tzu Lee; Te-Li Chen; Leung-Kei Siu; Chien-Pei Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

4.  Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.

Authors:  Alix Pantel; Catherine Dunyach-Remy; Christelle Ngba Essebe; Jennifer Mesureur; Albert Sotto; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine; Jean-Philippe Lavigne
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.

Authors:  Aurélie Thiolas; Claude Bollet; Bernard La Scola; Didier Raoult; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.

Authors:  Zhan Zhang; Zhi-Qiang Liu; Peng-Yuan Zheng; Fu-Ai Tang; Ping-Chang Yang
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

7.  Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily.

Authors:  Martine Braibant; Jacqueline Chevalier; Elisabeth Chaslus-Dancla; Jean-Marie Pagès; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey.

Authors:  Ufuk Over Hasdemir; Jacqueline Chevalier; Patrice Nordmann; Jean-Marie Pagès
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes.

Authors:  Renaud Chollet; Jacqueline Chevalier; Claude Bollet; Jean-Marie Pages; Anne Davin-Regli
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates.

Authors:  Monique Malléa; Abdallah Mahamoud; Jacqueline Chevalier; Sandrine Alibert-Franco; Pierre Brouant; Jacques Barbe; Jean-Marie Pagès
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.